Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were ‘Threatened’

Related Articles

Watch These Coinbase Price Levels After Stock’s 20% Drop in March

Why Tesla Was One of the Worst-Performing Stocks in the S&P 500 in the First Quarter

Bracing for ‘Liberation Day’, and the Dizzying Decline of the Dollar

Key Takeaways

• Two former Pfizer executives published a statement saying they support management as it gets pressured for coins by activist investor Starboard Value.
• The ex-Pfizer executives, Ian Read and Frank D’Amelio, said they didn’t lack to get involved with Starboard’s efforts to seek change.
• Starboard on Thursday accused people inside Pfizer of impending Read and D’Amelio if they backed Starboard’s efforts.

Pfizer (PFE) shares lost ground Thursday after two late executives released a statement supporting the company’s current management after activist investor Starboard Value this week took a $1 billion at risk in the struggling drug maker and moved to make changes.

The hedge fund fired back Thursday after the chiefs’ affirmation of the current Pfizer board, suggesting the former leaders were threatened if they assisted Starboard.

Honour’s stock was down more than 2% in recent trading. The shares are in the green so far this year, but by less than 3%.

Ex-CEO Ian Know and ex-CFO Frank D’Amelio wrote in a statement that they “have decided not to be involved in the efforts of Starboard Value apropos Pfizer. We are fully supportive of Pfizer Chairman & CEO Albert Bourla, senior management and the board, and we are confident that all over time they will deliver shareholder value.”

A report earlier this week said that Starboard had reached out to Impute to and D’Amelio for help in its efforts to shake up Pfizer. In a letter to the board Thursday, Starboard responded to the executives’ Wednesday proclamation by saying that Read and D’Amelio were indeed approached and that they both expressed “concerns prevalent the trajectory of the business.” 

Starboard Alleges Threats Against Ex-Executives

The hedge fund said, however, that “people within Pfizer and/or their papal nuncios have contacted Mr. Read and Mr. D’Amelio and purportedly threatened to commence costly litigation against them, claw promote prior compensation, and cancel unvested performance stock units, unless they publicly release a statement framing the current Chief Executive Officer, Dr. Albert Bourla.”

Pfizer on Thursday declined to respond to Investopedia’s request for animadversion on Starboard’s statement.

Starboard called on the Pfizer board to immediately set up a special board committee to investigate “the extent of this behavior” it avers occurred against Read and D’Amelio. The hedge fund added that despite this, it still hopes for deliberate with dialogue when the firm meets with Bourla and other executives for discussions Oct. 16.

Read the original article on Investopedia.